Original Research
Accepted on 14 Nov 2025
A T2-Weighted MRI Grading System for Preoperative Prediction of Visceral Pleural Invasion in Small Non-Small Cell Lung Cancers
in Thoracic Oncology
Frontiers in Oncology
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,874 articles
Original Research
Published on 14 Nov 2025
CD302 regulates the malignant phenotypes of lung adenocarcinoma as a tumor suppressor gene
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1601706
- 342 views
Mini Review
Published on 13 Nov 2025
AI-based prediction of pathological risk factors in lung adenocarcinoma from CT imaging: bridging innovation and clinical practice
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1687360
- 300 views
Original Research
Accepted on 11 Nov 2025
Machine Learning-Based Differentiation of Lung Squamous Cell Carcinoma and Adenocarcinoma Using Clinical-Semantic and Radiomic Features
in Thoracic Oncology
Frontiers in Oncology
Original Research
Accepted on 10 Nov 2025
Impact of KRAS G12C mutation on the efficacy of chemoradiotherapy in patients with unresectable stage II or III non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
Original Research
Published on 10 Nov 2025
18F-FAPI-04 PET/CT in the evaluation of ground-glass nodules less than 3 cm in diameter comparing to 18F-FDG PET/CT
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1605678
- 569 views
Case Report
Accepted on 07 Nov 2025
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report
in Thoracic Oncology
Frontiers in Oncology
- 314 views
Original Research
Accepted on 07 Nov 2025
Correlation analysis between EGFR gene mutation status, ALK positivity and demographic data, tumor biomarkers, radiological and pathological features in patients with lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
Original Research
Published on 07 Nov 2025
Predicting immunotherapy response in stage III-IV non-small cell lung cancer using integrated radiomics and clinical features
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1669469
- 402 views
Correction
Published on 07 Nov 2025
Correction: Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1720422
- 217 views
Original Research
Published on 06 Nov 2025
Analysis of short-term clinical efficacy and immune function changes of advanced non-small cell lung cancer after radiotherapy or chemotherapy under CT-guided 125I seed implantation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1667205
- 334 views
Case Report
Published on 06 Nov 2025
Case Report: Pitfalls in anatomic pathology and clinical oncology: a case of misdiagnosed pulmonary Ewing sarcoma as SCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1635424
- 623 views
Original Research
Accepted on 05 Nov 2025
Deciphering the let-7c-5p/RRM2 axis in lung adenocarcinoma: expression, prognosis, and immunelandscape implications
in Thoracic Oncology
Frontiers in Oncology
- 110 views
Systematic Review
Accepted on 04 Nov 2025
Synergistic Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined with Nab-Paclitaxel and Platinum Chemotherapy in NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
in Thoracic Oncology
Frontiers in Oncology
Original Research
Published on 04 Nov 2025
MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8 + T cell regulation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1642999
- 378 views
Case Report
Accepted on 03 Nov 2025
Radiation therapy alleviates Doege-Potter syndrome accompanied with severe aortic valve insufficiency: A Case Report and Literature Review
in Thoracic Oncology
Frontiers in Oncology